Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology.

Queiro R, Laiz A, Seoane-Mato D, Galindez Agirregoikoa E, Montilla C, Park HS, Bethencourt Baute JJ, Bustabad S, Pinto Tasende JA, Tejón P, Joven Ibáñez B, Ramírez J, Cuervo A, Cañete JD, Trenor Larraz P, Ordás C, Alonso S, García-Fernández E, Toniolo E, Moreno Ramos MJ, Beteta MD, Lojo Oliveira L, Navío Marco T, Cebrián L, Barbazán C, Maceiras F, Rodriguez-Moreno J, Steiner M, Muñoz-Fernández S, Nóvoa Medina FJ, León M, Rubio E, Medina Luezas J, Sánchez-González MD, Arévalo M, Gratacós J, Senabre JM, Rosas JC, Santos Soler G, Nieto-González JC, González C, López Robles A, Álvarez Castro C, Ruiz Montesino MD, Torrente-Segarra V, Fernández-Carballido C, Martínez-Vidal MP, Jovani V, Urruticoechea-Arana A, Cabello Fernández Y, Toledo MD, Almodóvar R, Belmonte-Serrano MÁ, Notario Ferreira I, Raya Álvarez E; Grupo de Trabajo del Proyecto REAPSER.

Reumatol Clin. 2018 Dec 3. pii: S1699-258X(18)30222-5. doi: 10.1016/j.reuma.2018.09.008. [Epub ahead of print] English, Spanish.

2.

Beyond orthogeriatric co-management model: benefits of implementing a process management system for hip fracture.

Brañas F, Ruiz-Pinto A, Fernández E, Del Cerro A, de Dios R, Fuentetaja L, Cebrián L, Larrainzar-Garijo R.

Arch Osteoporos. 2018 Jul 25;13(1):81. doi: 10.1007/s11657-018-0497-6.

PMID:
30046907
3.

SCORE study: quality indicators for rheumatology nursing clinics.

Muñoz-Fernández S, Aguilar MD, Almodóvar R, Cano-García L, Fortea S, Alcañiz-Escandell CP, Rodríguez JR, Cebrián L, Lázaro P; Representing the SCORE working group.

Rheumatol Int. 2017 Mar;37(3):353-361. doi: 10.1007/s00296-016-3644-7. Epub 2017 Jan 20.

PMID:
28108765
4.

Posterior circulation stroke after bronchial artery embolization. A rare but serious complication.

Laborda A, Tejero C, Fredes A, Cebrian L, Guelbenzu S, de Gregorio MA.

Cardiovasc Intervent Radiol. 2013 Jun;36(3):860-3. doi: 10.1007/s00270-012-0457-2. Epub 2012 Aug 7.

PMID:
22869045
5.

beta-lactam susceptibility of Escherichia coli isolates from urinary tract infections exhibiting different resistance phenotypes.

Lerma M, Cebrián L, Giménez M, Coronel P, Gimeno M, Aguilar L, García de Lomas J.

Rev Esp Quimioter. 2008 Sep;21(3):149-52.

6.

Evaluation of the in-vitro cidal activity and toxicity of a novel peroxygen biocide: 2-butanone peroxide.

García-de-Lomas J, Lerma M, Cebrián L, Esteban E, Giménez MJ, Aguilar L, Domínguez V, Randez JJ.

J Hosp Infect. 2008 Mar;68(3):248-54. doi: 10.1016/j.jhin.2007.12.011. Epub 2008 Mar 4.

PMID:
18289719
7.

Evaluation of several fluoroquinolones and beta-lactams in terms of their capability to restrict the selection of fluoroquinolone-resistant Salmonella: in vitro models.

Cebríán L, Rodríguez JC, Escribiano I, Royo SG.

APMIS. 2007 Dec;115(12):1376-82. doi: 10.1111/j.1600-0463.2007.00799.x.

PMID:
18184408
8.

Influence of Haemophilus influenzae beta-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins.

García-de-Lomas J, Lerma M, Cebrián L, Juan-Bañón JL, Coronel P, Giménez MJ, Aguilar L.

Int J Antimicrob Agents. 2007 Aug;30(2):190-2. Epub 2007 Apr 25. No abstract available.

PMID:
17459665
9.

[Decrease in bactericidal activity of ciprofloxacin in Salmonella mutants generated following repeated exposure to various fluorquinolones].

Cebrián L, Rodríguez JC, Escribano I, Ruiz M, Royo G.

Rev Esp Quimioter. 2006 Dec;19(4):363-6. Spanish.

10.

Alterations in the gyrA and parC genes in Salmonella spp. following in vitro exposure to fluoroquinolones.

Cebrian L, Escribano I, Rodriguez JC, Royo G.

J Chemother. 2006 Jun;18(3):250-4.

PMID:
17129834
11.

Relation between induction of the mar operon and cyclohexane tolerance and reduction in fluoroquinolone susceptibility in Salmonella spp.

Escribano I, Rodríguez JC, Pertegás V, Cebrian L, Royo G.

J Infect Chemother. 2006 Aug;12(4):177-80.

PMID:
16944254
12.
13.

Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.

Navarro D, Escribano A, Cebrián L, Gimeno C, García-Maset L, García-de-Lomas J; Spanish Pneumococcal Infection Study Network.

Clin Vaccine Immunol. 2006 Jun;13(6):665-70.

14.

[Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin].

Fenoll A, Robledo O, Lerma M, Giménez MJ, Cebrián L, Casal J, Aguilar L, Gómez-Lus ML.

Rev Esp Quimioter. 2006 Mar;19(1):39-44. Spanish.

15.

In vitro generation of Salmonella spp. mutants following repeated exposure to beta-lactam antibiotics.

Cebrián L, Rodríguez JC, Escribano I, Royo G.

J Infect Chemother. 2006 Apr;12(2):80-2.

PMID:
16648947
16.

Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis.

Rodríguez JC, Cebrián L, Ruiz M, López M, Royo G.

Chemotherapy. 2005 May;51(2-3):76-9. Epub 2005 May 4.

PMID:
15870500
17.

Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms.

Cebrián L, Rodríguez JC, Escribano I, Royo G.

Chemotherapy. 2005 Mar;51(1):40-3. Epub 2005 Mar 14.

PMID:
15767744
18.

[Expanded-spectrum beta-lactamase-producing strains of E. coli: origin, characteristics and incidence in Southern Alicante (Spain) in the period 1999-2003].

Yagüe A, Cebrián L, Rodríguez-Díaz JC, Gonzalo-Jiménez N, Royo G, Campillos P, López-Lozano JM.

Enferm Infecc Microbiol Clin. 2005 Feb;23(2):76-9. Spanish.

PMID:
15743578
19.

Usefulness of various antibiotics against Mycobacterium avium-intracellulare, measured by their mutant prevention concentration.

Rodríguez JC, Cebrián L, López M, Ruiz M, Royo G.

Int J Antimicrob Agents. 2005 Mar;25(3):221-5. Epub 2005 Jan 21.

PMID:
15737516
20.

Influence of various criteria for elimination of duplicates when calculating the prevalence and antibiotic susceptibility of microorganisms associated with urinary infections.

Cebrián L, Rodríguez JC, Escribano I, Cascales E, López-Lozano JM, Royo G.

Int J Antimicrob Agents. 2005 Feb;25(2):173-6.

PMID:
15664489

Supplemental Content

Loading ...
Support Center